These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 3114198)
21. Identification of early stages of T lymphocyte development in the thymus cortex and medulla. Scollay R; Shortman K J Immunol; 1985 Jun; 134(6):3632-42. PubMed ID: 3886788 [TBL] [Abstract][Full Text] [Related]
22. Interleukin-1 augments the interleukin-2-dependent generation of natural killer cells from bone marrow precursors. Migliorati G; Cannarile L; D'Adamio L; Herberman RB; Riccardi C Nat Immun Cell Growth Regul; 1987; 6(6):306-15. PubMed ID: 3502358 [TBL] [Abstract][Full Text] [Related]
23. Identification of cellular mechanisms operational in vivo during the regression of established pulmonary metastases by the systemic administration of high-dose recombinant interleukin 2. Mulé JJ; Yang JC; Afreniere RL; Shu SY; Rosenberg SA J Immunol; 1987 Jul; 139(1):285-94. PubMed ID: 3108401 [TBL] [Abstract][Full Text] [Related]
24. Heterogeneity of immature (Lyt-2-/L3T4-) thymocytes. Identification of four major phenotypically distinct subsets differing in cell cycle status and in vitro activation requirements. Howe RC; MacDonald HR J Immunol; 1988 Feb; 140(4):1047-55. PubMed ID: 3257768 [TBL] [Abstract][Full Text] [Related]
25. IL-4 inhibits IL-2 induction of LAK cytotoxicity in lymphocytes from a variety of lymphoid tissues. Colquhoun SD; Economou JS; Shau H; Golub SH J Surg Res; 1993 Nov; 55(5):486-92. PubMed ID: 8231167 [TBL] [Abstract][Full Text] [Related]
26. Natural killer (NK) cells as a responder to interleukin 2 (IL 2). I. Proliferative response and establishment of cloned cells. Suzuki R; Handa K; Itoh K; Kumagai K J Immunol; 1983 Feb; 130(2):981-7. PubMed ID: 6600260 [TBL] [Abstract][Full Text] [Related]
27. Expression and function of LFA-1 on A-NK and T-LAK cells: role in tumor target killing and migration into tumor tissue. Donskov F; Basse PH; Hokland M Nat Immun; 1996-1997; 15(2-3):134-46. PubMed ID: 9162263 [TBL] [Abstract][Full Text] [Related]
28. Lymphokine-activated killer cells in rats: analysis of tissue and strain distribution, ontogeny, and target specificity. Vujanovic NL; Herberman RB; Hiserodt JC Cancer Res; 1988 Feb; 48(4):878-83. PubMed ID: 3257411 [TBL] [Abstract][Full Text] [Related]
29. Interleukin 2 induces human acute lymphocytic leukemia cells to manifest lymphokine-activated-killer (LAK) cytotoxicity. Kaufmann Y; Levanon M; Davidsohn J; Ramot B J Immunol; 1987 Aug; 139(3):977-82. PubMed ID: 3496395 [TBL] [Abstract][Full Text] [Related]
30. Heterogeneity of lymphokine-activated killer cells induced by IL-2. Separate lymphoid subpopulations lyse tumor, allogeneic blasts, and modified syngeneic blasts. LeFor AT; Eisenthal A; Rosenberg SA J Immunol; 1988 Jun; 140(11):4062-9. PubMed ID: 3259603 [TBL] [Abstract][Full Text] [Related]
31. Functional maturation of thymocytes: recruitment of helper cells in the humoral immune response to SRBC in vitro by recombinant interleukin 1 (Il-1). Zimecki M; Wieczorek Z Arch Immunol Ther Exp (Warsz); 1989; 37(3-4):331-8. PubMed ID: 2534786 [TBL] [Abstract][Full Text] [Related]
32. Lymphokine-activated killer cells in rats. IV. Developmental relationships among large agranular lymphocytes, large granular lymphocytes, and lymphokine-activated killer cells. Maghazachi AA; Vujanovic NL; Herberman RB; Hiserodt JC J Immunol; 1988 Apr; 140(8):2846-52. PubMed ID: 3258622 [TBL] [Abstract][Full Text] [Related]
33. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma. Muralikrishna K; Varalakshmi C; Khar A Cytokines Cell Mol Ther; 1997 Mar; 3(1):51-8. PubMed ID: 9287244 [TBL] [Abstract][Full Text] [Related]
34. Characteristics of murine non-specific killer cells induced in vivo by recombinant human interleukin-2. Hinuma S; Naruo K; Shiho O; Tsukamoto K Immunology; 1986 Oct; 59(2):251-9. PubMed ID: 3490435 [TBL] [Abstract][Full Text] [Related]
35. Proliferation in vitro and interleukin production by 14 day fetal and adult Lyt-2-/L3T4- mouse thymocytes. Ceredig R J Immunol; 1986 Oct; 137(7):2260-7. PubMed ID: 3093570 [TBL] [Abstract][Full Text] [Related]
36. Effects of transforming growth factor-beta on human lymphokine-activated killer cell precursors. Autocrine inhibition of cellular proliferation and differentiation to immune killer cells. Kasid A; Bell GI; Director EP J Immunol; 1988 Jul; 141(2):690-8. PubMed ID: 3133414 [TBL] [Abstract][Full Text] [Related]
37. Intrathymic differentiation of cytotoxic T lymphocyte (CTL) precursors. I. The CTL immunocompetence of peanut agglutinin-positive (cortical) and negative (medullary) Lyt 123 thymocytes. Wagner H; Hardt C; Bartlett R; Röllinghoff M; Pfizenmaier K J Immunol; 1980 Dec; 125(6):2532-8. PubMed ID: 6159411 [TBL] [Abstract][Full Text] [Related]
39. Immunohistology of lymphoid and non-lymphoid cells in the thymus in relation to T lymphocyte differentiation. Van Ewijk W Am J Anat; 1984 Jul; 170(3):311-30. PubMed ID: 6332520 [TBL] [Abstract][Full Text] [Related]
40. Generation of lymphokine-activated killer cells in strain 2 guinea pigs and their use in the therapy of L2C, an acute B-cell leukemia. Gregg EO; Gregg IC; Green I Cancer Res; 1987 Feb; 47(3):723-9. PubMed ID: 3492265 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]